Claudia Gulea1,2, Rosita Zakeri3,4, Jennifer K Quint5,6,4. 1. Department of Population Health, National Heart and Lung Institute, Imperial College London, London, UK. c.gulea18@imperial.ac.uk. 2. NIHR Imperial Biomedical Research Centre, London, UK. c.gulea18@imperial.ac.uk. 3. British Heart Foundation Centre for Research Excellence, King's College London, London, UK. 4. Royal Brompton & Harefield NHS Foundation Trust, London, UK. 5. Department of Population Health, National Heart and Lung Institute, Imperial College London, London, UK. 6. NIHR Imperial Biomedical Research Centre, London, UK.
Abstract
BACKGROUND: Comorbidities affect outcomes in heart failure (HF), but are not reflected in current HF classification. The aim of this study is to characterize HF groups that account for higher-order interactions between comorbidities and to investigate the association between comorbidity groups and outcomes. METHODS: Latent class analysis (LCA) was performed on 12 comorbidities from patients with HF identified from administrative claims data in the USA (OptumLabs Data Warehouse®) between 2008 and 2018. Associations with admission to hospital and mortality were assessed with Cox regression. Negative binomial regression was used to examine rates of healthcare use. RESULTS: In a population of 318,384 individuals, we identified five comorbidity clusters, named according to their dominant features: low-burden, metabolic-vascular, anemic, ischemic, and metabolic. Compared to the low-burden group (minimal comorbidities), patients in the metabolic-vascular group (exhibiting a pattern of diabetes, obesity, and vascular disease) had the worst prognosis for admission (HR 2.21, 95% CI 2.17-2.25) and death (HR 1.87, 95% CI 1.74-2.01), followed by the ischemic, anemic, and metabolic groups. The anemic group experienced an intermediate risk of admission (HR 1.49, 95% CI 1.44-1.54) and death (HR 1.46, 95% CI 1.30-1.64). Healthcare use also varied: the anemic group had the highest rate of outpatient visits, compared to the low-burden group (IRR 2.11, 95% CI 2.06-2.16); the metabolic-vascular and ischemic groups had the highest rate of admissions (IRR 2.11, 95% CI 2.08-2.15, and 2.11, 95% CI 2.07-2.15) and healthcare costs. CONCLUSIONS: These data demonstrate the feasibility of using LCA to classify HF based on comorbidities alone and should encourage investigation of multidimensional approaches in comorbidity management to reduce admission and mortality risk among patients with HF.
BACKGROUND: Comorbidities affect outcomes in heart failure (HF), but are not reflected in current HF classification. The aim of this study is to characterize HF groups that account for higher-order interactions between comorbidities and to investigate the association between comorbidity groups and outcomes. METHODS: Latent class analysis (LCA) was performed on 12 comorbidities from patients with HF identified from administrative claims data in the USA (OptumLabs Data Warehouse®) between 2008 and 2018. Associations with admission to hospital and mortality were assessed with Cox regression. Negative binomial regression was used to examine rates of healthcare use. RESULTS: In a population of 318,384 individuals, we identified five comorbidity clusters, named according to their dominant features: low-burden, metabolic-vascular, anemic, ischemic, and metabolic. Compared to the low-burden group (minimal comorbidities), patients in the metabolic-vascular group (exhibiting a pattern of diabetes, obesity, and vascular disease) had the worst prognosis for admission (HR 2.21, 95% CI 2.17-2.25) and death (HR 1.87, 95% CI 1.74-2.01), followed by the ischemic, anemic, and metabolic groups. The anemic group experienced an intermediate risk of admission (HR 1.49, 95% CI 1.44-1.54) and death (HR 1.46, 95% CI 1.30-1.64). Healthcare use also varied: the anemic group had the highest rate of outpatient visits, compared to the low-burden group (IRR 2.11, 95% CI 2.06-2.16); the metabolic-vascular and ischemic groups had the highest rate of admissions (IRR 2.11, 95% CI 2.08-2.15, and 2.11, 95% CI 2.07-2.15) and healthcare costs. CONCLUSIONS: These data demonstrate the feasibility of using LCA to classify HF based on comorbidities alone and should encourage investigation of multidimensional approaches in comorbidity management to reduce admission and mortality risk among patients with HF.
Entities:
Keywords:
Comorbidity; Hospitalization; Mortality; Resource use
Authors: Matthew W Segar; Kershaw V Patel; Colby Ayers; Mujeeb Basit; W H Wilson Tang; Duwayne Willett; Jarett Berry; Justin L Grodin; Ambarish Pandey Journal: Eur J Heart Fail Date: 2019-10-21 Impact factor: 15.534
Authors: Anders Mälarstig; Daniel Ziemek; Lars Lund; Åsa K Hedman; Camilla Hage; Anil Sharma; Mary Julia Brosnan; Leonard Buckbinder; Li-Ming Gan; Sanjiv J Shah; Cecilia M Linde; Erwan Donal; Jean-Claude Daubert Journal: Heart Date: 2020-01-07 Impact factor: 5.994
Authors: Gülmisal Güder; Stefan Frantz; Johann Bauersachs; Bruno Allolio; Christoph Wanner; Michael T Koller; Georg Ertl; Christiane E Angermann; Stefan Störk Journal: Circ Heart Fail Date: 2009-09-24 Impact factor: 8.790
Authors: Daniel E Forman; Christopher P Cannon; Adrian F Hernandez; Li Liang; Clyde Yancy; Gregg C Fonarow Journal: Am Heart J Date: 2009-04-25 Impact factor: 4.749
Authors: Andreas Karwath; Karina V Bunting; Simrat K Gill; Otilia Tica; Samantha Pendleton; Furqan Aziz; Andrey D Barsky; Saisakul Chernbumroong; Jinming Duan; Alastair R Mobley; Victor Roth Cardoso; Luke Slater; John A Williams; Emma-Jane Bruce; Xiaoxia Wang; Marcus D Flather; Andrew J S Coats; Georgios V Gkoutos; Dipak Kotecha Journal: Lancet Date: 2021-08-30 Impact factor: 79.321